Several studies have demonstrated the therapeutic efficacy of mTOR inhibitors on suppressing tumor growth in a number of solid tumors on human subcutaneous growing xenografts [19, 21, 60] and in many phase I–III clinical studies [16, 17, 32]. This evidence concerns the gene MTOR and neoplasm.